Session 903: Intervention strategies

Cochair(s): H Vainio, RM Blaese
Date: 10 February 2004, Time: 08:30 - 11:00
Location: Room 1

Oral Presentations

Time	Number	Title / Authors / Affiliations
08:30	345	Immune responses to human tumors: development of tumor vaccines CD Platsoucas PhD^a, J Pappas^a, M Heckel^a, W-J Jung^a, JE Fincke^a, CD Katsetos^a,b, R Schwarting^c, RS Freedman^d ^aDepartment of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, PA, United States, ^bDepartment of Pediatrics, Section of Neurology, Drexel University College of Medicine, Philadelphia, PA, United States, ^cDepartment of Pathology, Anatomy and Cell Biology, Thomas Jefferson Medical College, Philadelphia, PA, United States, ^dDepartment of Gynecologic Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, United States
08:55	346	Recombinant Cancer Vaccines: Design and Development JW Hodge PhD, M Chakraborty PhD, KY Tsang PhD, JW Greiner PhD, J Schlom PhD Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 8B09, MSC 1750, Bethesda, MD 20892-1750 (e-mail: jh241d@nih.gov). James W. Hodge, Director, Recombinant Vaccine Group, Laboratory of Tumor Immunology and Biology, CCR, NCI, NIH. Jeffrey Schlom, Chief, Laboratory of Tumor Immunology and Biology, CCR, NCI, NIH.
09:20	347	Toll-like receptors: immunodeficiency and cancer S Haraguchi PhD, NK Day PhD Division of Allergy and Immunology, Department of Pediatrics, University of South Florida, All Children's Hospital, St. Petersburg, Florida, United States
09:45	348	Retroviral-related peptides: not just for immunosuppression anymore GJ Cianciolo PhD, F Wang BA, A Harris, SV Pizzo MD PhD Department of Pathology, Duke University Medical Center, Durham, NC, United States
10:10	349	Trouble in the Fas Lane: Lessons Learned from an "Experiment of Nature" TA Fleisher MD DLM, CC, National Institutes of Health, DHHS, Bethesda, MD, USA